IFOSFAMIDE/MESNA KIT Drug Patent Profile
✉ Email this page to a colleague
When do Ifosfamide/mesna Kit patents expire, and when can generic versions of Ifosfamide/mesna Kit launch?
Ifosfamide/mesna Kit is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in IFOSFAMIDE/MESNA KIT is ifosfamide; mesna. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ifosfamide; mesna profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IFOSFAMIDE/MESNA KIT?
- What are the global sales for IFOSFAMIDE/MESNA KIT?
- What is Average Wholesale Price for IFOSFAMIDE/MESNA KIT?
Summary for IFOSFAMIDE/MESNA KIT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 456 |
| DailyMed Link: | IFOSFAMIDE/MESNA KIT at DailyMed |
Recent Clinical Trials for IFOSFAMIDE/MESNA KIT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| BeBetter Med Inc | Phase 1 |
| Exelixis | Phase 1 |
| Children's Hospital Colorado | Phase 1 |
US Patents and Regulatory Information for IFOSFAMIDE/MESNA KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | IFOSFAMIDE/MESNA KIT | ifosfamide; mesna | INJECTABLE;INTRAVENOUS | 075874-001 | Feb 26, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms Usa | IFOSFAMIDE/MESNA KIT | ifosfamide; mesna | INJECTABLE;INTRAVENOUS | 075874-002 | Feb 26, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
